GLC Biotechnology Inc.

Hudson, OH

UEI
ETKMDA959PF6
CAGE
47K43
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
7925 Megan Meadow Dr, Hudson, OH 44236, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of an innovative tee technology for mutation detection R44CA284965 National Cancer Institute (NIH) $3,071,306
A novel method for efficiently and robustly retrieving circulating mirnas R44GM134758 National Institute of General Medical Sciences (NIH) $1,500,000
Development of a novel liquid biopsy test to assist targeted MSI-h cancer treatment R43CA232914 National Cancer Institute (NIH) $225,000
A method for quantitatively retrieving circulating mirnas from plasma R43GM117698 National Institute of General Medical Sciences (NIH) $225,000
Fecal DNA testing for colorectal cancer screening R43CA183170 National Institutes of Health $225,000

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is GLC Biotechnology Inc. registered in SAM.gov?

Yes. GLC Biotechnology Inc.'s SAM.gov registration is active through December 18, 2026.

What is GLC Biotechnology Inc.'s most recent federal award?

GLC Biotechnology Inc.'s most recent federal grant award is Development of an innovative tee technology for mutation detection (R44CA284965), from National Cancer Institute (NIH), on September 18, 2023.

On GovTribe

See GLC Biotechnology Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login